Workshop on Progressive MS and NMO-SD - Ljubljana 2025
Our workshop is a must-attend learning and networking experience for all professionals passionate about rehabilitation and improving care for people living with multiple sclerosis.
Speakers
-
Alenka Horvat Ledinek
Neurologist at University Medical Centre Ljubljana, Slovenia, heading the MS Centre at the Neurology Clinic. Experienced in diagnosis, treatment and research into multiple sclerosis, with special interest in disease-modifying therapies and new treatment approaches. Co-author of cross-national studies of MS therapies and active voice in public education about MS. -
Gregor Brecl
Neurologist based in Ljubljana, leading the Multiple Sclerosis Center in the Neurology Department at University Medical Centre Ljubljana. Research interests include early diagnosis, MRI-based prediction of disability progression, cognitive-motor interference and treatment trends in MS. Has published on long-term use of disease-modifying therapies in Slovenia. -
Jana Pöttgen
Clinical psychologist and neuropsychologist specializing in MS at University Medical Center Hamburg-Eppendorf, Germany. Focuses on neuropsychiatric aspects of MS including fatigue, sexual dysfunction, outcome measure development, psychotherapeutic and eHealth interventions. Has published substantial systematic reviews, RCTs and work on patient-reported outcome measures. -
Louisin Moumdjian
Rehabilitation researcher and postdoctoral scholar at Hasselt University and Ghent University, Belgium. Specialises in auditory-motor coupling, gait and rhythm-based rehabilitation, music and rhythm interventions, and motor-cognitive dual-task performance in people with MS. Active in designing embodied learning and feedback-based interventions to improve mobility and reduce fatigue. She is also a member of RiMS Executive Board as SIG Officer. -
Uros Rot
Neurologist in Slovenia, affiliated with the University Medical Centre Ljubljana; co-author of major national studies evaluating disease-modifying therapy use over decades. Involved in tracking treatment trends and outcomes in Slovenian MS populations, with interests in long-term management and optimizing therapy choices.